Stocks & Equities

TSX Stocks: Why This Investment Strategy Could Make a Comeback

Posted by Victoria Hetherington

on Friday, 1 May 2020 11:18

Value investing is one style that could come back into fashion with a bang this year. Value stocks have been in the bargain basement of the investment world for some time now. The bull market didn’t support them, and the market crash just pushed them further down. The ratio of value to growth stock popularity is now as low as it was two decades ago. That said, thing could be about to change.

Gold stocks in particular could come roaring back. While they’ve remained resilient during the market crash, many miners of the precious metal are still undervalued. Earnings season is going to be of particular interest to long-term investors.

It’s likely to be a rough quarter across the board, further depressing share prices, which in turn could help draw interest in beaten-up quality names. CLICK for complete article

A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio

Posted by Shanthi Rexaline

on Monday, 27 April 2020 10:24

Among the six coronavirus vaccine candidates that have entered human trials, two belong to publicly listed U.S. companies: Moderna Inc and Inovio Pharmaceuticals Inc Both stocks have rallied in reaction to updates on R&D and funding.

Moderna is up about 143% year-to-date and Inovio is higher by 265%.

Moderna, Inovio’s Vaccine Candidates

Both Moderna and Inovio use a modern approach as opposed to conventional vaccines that employ a weakened form of the pathogen, a killed pathogen or specific pieces of pathogen such as its protein, sugar or capsid.

Moderna is developing mRNA-1273, an mRNA vaccine, against the new coronavirus in collaboration with the Vaccine Research Center at the NIH’s National Institute of Allergy and Infectious Diseases. It is a vaccine against SARS-CoV-2 encoding for the spike, or S, protein….CLICK for complete article

A Faster Vaccine Could Spark a Market Rally

Posted by Daniel De Costa

on Wednesday, 22 April 2020 10:28

The last few weeks have seen markets rally, as the virus has become more contained. Now, there is even more optimism around the potential arrival of a vaccine sooner than experts had been expecting.

Much of the selloff in stocks was regarding the uncertainty going forward. In addition to not knowing how long it will take to control the spread of the virus completely, we also don’t know what it will take to reopen the economy successfully.

Some have said mass testing will be sufficient, while others have said that won’t be enough. One thing’s for sure, though; a successful vaccine is the only sure way to get over this.

Last week, it was reported that Gilead Sciences saw early positive signs from its coronavirus vaccine testing. This suggests a vaccine could be ready sooner than the market had expected….CLICK for complete article

Who knew? Fearless Millennials are cashing in on stocks as frightened Boomers cash out

Posted by Victor Ferreira

on Monday, 20 April 2020 11:13

Turns out millennials have been sitting on an abundance of savings and they are using that to aggressively buy the coronavirus dip.

Barry Schwartz spent most of March trying to talk his clients off of two distinct ledges.

A typical hour might have seen the chief investment officer at Baskin Wealth Management try to convince an emotional retiree to not panic and cash out, before having to pivot and  temper the bet-it-all instincts of a millennial client with $50,000 burning a hole in their pocket.

While the former was not unexpected for the wealth management veteran, the latter was something new. And it wasn’t just one or two millennials under his care wanting to buy the dip after stocks plunged 30 per cent — it was all of them. The millennial generation may have a lousy reputation as investors, but they’ve played this stock market swoon better than their baby boomer rivals, Schwartz admits….CLICK for complete article

9 Worst-Performing Stocks Of 2020: Buy, Sell Or Hold?

Posted by Wayne Duggan

on Thursday, 16 April 2020 10:10

The S&P 500 has rallied hard off its March lows, but the index remains down 12.4% year-to-date overall. The near-term economic outlook amid the COVID-19 shutdown is still unclear, creating a lot of uncertainty on Wall Street. The International Monetary Fund cut its 2020 global economic growth forecast to negative 3% this week.

A number of stocks have been hit much harder than the 12.4% overall market decline. Some of those stocks will ultimately prove excellent long-term buying opportunities. Some of them will end up dropping significantly lower.

Here’s what analysts have to say about the nine worst-performing S&P 500 stocks of 2020….CLICK for complete article